I1NC34 SAO Week ended 31 Jul 2026

Weekly Investor Report

Name: I1NC34 weekly investor report
Creator: Sharemaestro
License: https://sharemaestro.com/data-license/

Incyte Corporation · Healthcare · Biotechnology

Open interactive chart View report data

Latest close 305.7 BRL

3.6% latest week

Weekly setup

Constructive, but selective

The weekly trend is active. Price is 16.4% above the Trend Line and sits at 99.2% of its 52-week range. The latest completed week returned 3.6%, after a 2.9% four-week move. The latest news-sentiment score is 56/100. Near-term considerations: price is close to its 52-week high; volume confirmation is below normal.

Setup score 54 out of 100

Latest Close 305.7 BRL 31 Jul 2026

1W Return 3.6% latest completed week

4W Return 2.9% short-term follow-through

12W Return 27.1% quarterly tape

Trend Breadth 53.8% 28 of 52 weeks active

Volume Ratio 0.6x vs 13-week average

What is working

The trend backdrop is active with a 2-week active streak.
Price is above the Trend Line, keeping the weekly tape constructive.
Price is above Fair Value, showing premium demand versus the model.
Activity pressure is positive on the latest completed week.

What could go wrong

Next-week expectancy is negative at 25.76% based on similar historical setup states.
2 reversal markers appear in the recent smart-money tape.

What to watch next

Price is close to its 52-week high; watch for continuation or exhaustion.
Trend Line remains the key weekly regime level.
Activity pressure is the gauge to monitor for confirmation or fade.
A volume ratio above 1.5x would show stronger participation in the next move.

Price follow-through 3.6% Latest completed week; four-week move 2.9%. Indicator stack 37/70 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Next-Week Expectancy Negative 25.76% Historical one-week expectancy contributes to the evidence score when direction is confirmed. News sentiment 56/100 14 relevant articles in the latest sentiment read.

01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 16.4% above the Trend Line and sits at 99.2% of its 52-week range. The latest completed week returned 3.6%, after a 2.9% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value

Price Trend Line Fair Value

Position in the 52-week range

Close Trend Fair

189.6 BRL 99.2% 306.6 BRL

Range location99.2%Shows where the latest close sits between the 52-week low and high.

Trend distance16.4%Price premium or discount versus the weekly Trend Line.

Fair-value gap49.5%Premium demand or model discount versus Sharemaestro Fair Value.

High-water gap-0.3%Distance from the latest 52-week high.

02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.6x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction

6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul

Up week Down week

Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.5712-week average 0.24

12-week confirmation

Trend active2/12Active trend-backdrop weeks in the latest 12-week window.

Positive pressure7/12Weeks with constructive activity pressure in the latest 12-week window.

Positive leadership7/12Weeks with positive relative leadership in the latest 12-week window.

Activity pressure0.57Current proprietary activity-pressure read.

Buy signals0Accumulation signal count in the latest 12 weeks.

Reversal markers22 reversal markers

No recent accumulation markers. 2 reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 2.9% over four weeks, 27.1% over 12 weeks, and 61.2% over one year. The current trend has remained active for 2 consecutive weeks.

Performance by holding period

1W3.6%

4W2.9%

12W27.1%

26W15.5%

52W61.2%

Active trend streak2 weeks

Active weeks in one year28

Trend breadth53.8%

Activity pressure vs relative leadership

Activity pressureRelative leadership

Pressure1.02Latest activity-pressure read.

Pressure change24.1%Four-week change in activity pressure.

Leadership10.57Latest relative-leadership reading.

RS change-6.7%Four-week change in relative leadership.

04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

A published fundamentals and factor snapshot is not available for this company.

Open full factor analysis

No published fundamental snapshot is available for this company.

05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment56/100

Weighted news tone is neutral across 14 relevant articles.

5 positive · 8 neutral · 1 negative

Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal

06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings-No event is currently stored.

Options expected move-Nearest-chain priced movement where available.

52-week drawdown-0.3%Distance below the 52-week high.

13-week volatility6.1%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

6 Feb 6 Mar 3 Apr 1 May 29 May 26 Jun 31 Jul

Weeks higher11 of 2614 weeks finished lower.

Best week+15.2%Week of 26 Jun.

Worst week-7.0%Week of 19 Jun.

Latest week+3.6%Week of 31 Jul.

Shape of recent returns

Strong gains4

Modest gains7

Flat weeks1

Modest losses13

Sharp losses1

Recent vol6.1%13-week weekly-return volatility.

Base vol5.3%52-week weekly-return volatility.

Up/down split22/23Count of positive and negative weeks in the 52-week window.

Average skew5.2% / -2.6%Average positive week versus average negative week.

07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

SectorBR Healthcare

4-week rank23 / 81

Group average-2.9%

Trend breadth30.9%

Trend30.9%active weekly trend signals

MD65.4%positive activity pressure

RS37.0%positive relative leadership

Four-week leaders

D1EX34 · SAO20.8%I1QV34 · SAO16.8%B1AX34 · SAO14.3%REGN34 · SAO13.6%PNVL3 · SAO9.3%

IndustryBR Biotechnology

4-week rank4 / 13

Group average-10.1%

Trend breadth30.8%

Trend30.8%active weekly trend signals

MD69.2%positive activity pressure

RS23.1%positive relative leadership

Four-week leaders

REGN34 · SAO13.6%B1ME34 · SAO8.0%B1MR34 · SAO4.8%I1NC34 · SAO2.9%T1CH34 · SAO-1.1%

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape50/100

Trend, activity pressure, participation, and risk combine to a 50/100 tape read.

Indicator analysis42/100

Latest 12-week confirmation: trend 2/12, activity pressure 7/12, relative leadership 7/12.

Activity pressure 0.57; 2 reversal markers Next-Week ExpectancyNegative 25.76%

Next-week expectancy is negative with a 25.76% historical one-week setup read.

Adds short-term historical context without overriding trend, activity, or relative leadership. Factors50/100

No published factor snapshot is available yet.

Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Sentiment56/100

Weighted news tone is neutral across 14 relevant articles.

$127.49 Incyte stock slips 1.88% after bullish run, Incyte focuses on atopic dermatitis awareness Insiders50/100

No recent insider transaction evidence is stored.

Earnings50/100

No stored earnings event is currently attached to this ticker.

Week	Close	Return	Trend Line	Fair Value	Pressure	Leadership	Volume	Trend
31 Jul 2026	305.7 BRL	3.6%	262.7 BRL	204.5 BRL	1.02	10.57	65	On
24 Jul 2026	295.0 BRL	-1.8%	261.7 BRL	203.5 BRL	1.09	9.53	155	On
17 Jul 2026	300.3 BRL	0.0%	261.1 BRL	202.6 BRL	1.06	12.09	0	Off
10 Jul 2026	300.3 BRL	1.1%	260.1 BRL	201.6 BRL	0.90	9.89	1	Off
3 Jul 2026	297.0 BRL	1.7%	258.7 BRL	200.7 BRL	0.83	11.33	436	Off
26 Jun 2026	292.0 BRL	15.2%	258.1 BRL	199.7 BRL	0.35	10.60	5	Off
19 Jun 2026	253.5 BRL	-7.0%	257.7 BRL	198.8 BRL	0.11	-0.93	0	Off
12 Jun 2026	272.4 BRL	14.4%	258.5 BRL	198.1 BRL	-0.23	5.04	88	Off
5 Jun 2026	238.1 BRL	-2.4%	258.9 BRL	197.4 BRL	-0.78	-6.83	0	Off
29 May 2026	244.0 BRL	1.4%	260.3 BRL	196.8 BRL	-0.93	-7.14	571	Off
22 May 2026	240.7 BRL	0.8%	260.4 BRL	196.2 BRL	-1.19	-9.47	101	Off
15 May 2026	238.9 BRL	-0.7%	260.6 BRL	195.7 BRL	-1.29	-10.57	26	Off
8 May 2026	240.5 BRL	-2.7%	260.3 BRL	195.3 BRL	-1.29	-13.18	20	Off
1 May 2026	247.2 BRL	4.7%	259.9 BRL	194.8 BRL	-1.27	-12.53	51	Off

How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.